By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

Winter brings less daylight and colder temperatures, which can disrupt sleep. Seasonal Affective Disorder (SAD) is more ...

New Guideline Provides Treatment Recommendations for Restless ... a common yet underdiagnosed sleep disorder, contributes to the development of dementia among adults -- particularly women, a ...

New research reveals how sleep apnea may accelerate brain aging and cognitive decline, with experts sharing crucial insights ...

More than 60 million Americans battle insomnia, and counting sheep, reading dull books or skipping naps isn't helping. Here ...

The agency’s decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance ...

(Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for ...

In today’s fast-paced world, where stress and fatigue are commonplace, finding effective ways to enhance our well-being has ...

The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.

Depression, which doctors may call major depressive disorder, is a treatable ... You may need separate treatment for both depression and sleep problems. Common medications for depression like ...

Misdiagnosis happens in youngsters as it’s easy to dismiss symptoms as mood swings or work-induced stress, says psychiatrist ...